118 related articles for article (PubMed ID: 24640677)
1. [Characteristics of stromal cell precursors in patients after allogeneic bone marrow transplantation].
Petinati NA; Shipunova IN; Bigil'deev AE; Kuz'mina LA; Saribekian RA; Gal'tseva IV; Misiurin AV; Parovichnikova EN; Savchenko VG; Drize NI
Ter Arkh; 2013; 85(12):95-9. PubMed ID: 24640677
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation.
Shipounova IN; Petinati NA; Bigildeev AE; Drize NJ; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
Leuk Lymphoma; 2017 Feb; 58(2):408-417. PubMed ID: 27244369
[TBL] [Abstract][Full Text] [Related]
3. The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice.
de Mayo T; Conget P; Becerra-Bayona S; Sossa CL; Galvis V; Arango-Rodríguez ML
PLoS One; 2017; 12(6):e0177533. PubMed ID: 28594903
[TBL] [Abstract][Full Text] [Related]
4. Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
Wu L; Mo W; Zhang Y; Zhou M; Li Y; Zhou R; Xu S; Pan S; Deng H; Mao P; Wang S
Int J Hematol; 2017 Jul; 106(1):71-81. PubMed ID: 28303517
[TBL] [Abstract][Full Text] [Related]
5. Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Kong Y; Hu Y; Zhang XH; Wang YZ; Mo XD; Zhang YY; Wang Y; Han W; Xu LP; Chang YJ; Huang XJ
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1190-7. PubMed ID: 24792870
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of donor bone marrow multipotent mesenchymal stromal cells implanted into the periosteum of patients with allogeneic graft failure.
Kuzmina LA; Petinati NA; Sats NV; Drize NJ; Risinskaya NV; Sudarikov AB; Vasilieva VA; Drokov MY; Michalzova ED; Parovichnikova EN; Savchenko VG
Int J Hematol; 2016 Sep; 104(3):403-7. PubMed ID: 27169613
[TBL] [Abstract][Full Text] [Related]
7. [Expanding capacity of mesenchymal stem cells from patients after hematopoietic stem cell transplantation].
Wang J; Liu KY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):120-5. PubMed ID: 18315914
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 beta enhances human multipotent mesenchymal stromal cell proliferative potential and their ability to maintain hematopoietic precursor cells.
Bigildeev AE; Zezina EA; Shipounova IN; Drize NJ
Cytokine; 2015 Feb; 71(2):246-54. PubMed ID: 25461405
[TBL] [Abstract][Full Text] [Related]
9. [Randomized clinical study for two types of recombinant human granulocyte colony-stimulating factor mobilizing peripheral blood and bone marrow stem cells in patients receiving allogeneic hematopoietic stem cell transplantation].
Zhang XH; Huang XJ; Liu DH; Liu KY; Han W; Chen H; Wang FR; Chen YH; Wang JZ; Zhao T; Wang Y; Xu LP
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2116-9. PubMed ID: 20058615
[TBL] [Abstract][Full Text] [Related]
10. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study.
Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O
Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
12. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
[TBL] [Abstract][Full Text] [Related]
13. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
14. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
15. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia.
Ikegawa S; Doki N; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe D; Hagino T; Yoshioka K; Watakabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Pathol Oncol Res; 2017 Apr; 23(2):433-437. PubMed ID: 28004352
[TBL] [Abstract][Full Text] [Related]
16. Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.
Kuzmina LA; Petinati NA; Shipounova IN; Sats NV; Bigildeev AE; Zezina EA; Popova MD; Drize NJ; Parovichnikova EN; Savchenko VG
Eur J Haematol; 2016 Apr; 96(4):425-34. PubMed ID: 26115424
[TBL] [Abstract][Full Text] [Related]
17. [Effect of intra-bone marrow infusion of allogeneic mesenchymal stem cells on reconstruction of marrow mesenchymal stem cells in rat HSCT models].
Cai Y; Huang SL; Chen HQ; Huang YL; Huang K; Zhang XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1334-8. PubMed ID: 19099639
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation.
Tauchmanovà L; Serio B; Del Puente A; Risitano AM; Esposito A; De Rosa G; Lombardi G; Colao A; Rotoli B; Selleri C
J Clin Endocrinol Metab; 2002 Nov; 87(11):5058-65. PubMed ID: 12414872
[TBL] [Abstract][Full Text] [Related]
19. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
Gifford G; Sim J; Horne A; Ma D
Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of curative efficacy after G-CSF-mobilized sibling HLA-matched peripheral blood hematopoietic stem cell transplantation versus that combined with BMT for patients with hematologic malignancies in a single center].
Ren FP; Liu HL; Sun ZM; Geng LQ; Wang XB; Ding KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):404-9. PubMed ID: 21518497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
